<DOC>
	<DOCNO>NCT01031355</DOCNO>
	<brief_summary>Investigation bioequivalence ( BE ) Estradiol Valerate ( EV ) administration one film-coated tablet contain 3 mg Estradiol Valerate 0.451 mg Levomefolate calcium compare one film-coated tablet contain 3 mg Estradiol Valerate Investigation bioequivalence levomefolate calcium administration one film-coated tablet contain 3 mg Estradiol Valerate 0.451 mg Levomefolate calcium compare one film-coated tablet contain 0.451 mg levomefolate calcium</brief_summary>
	<brief_title>Bioequivalence Study : 3 mg Estradiol Valerate ( EV ) With Without Levomefolate Calcium</brief_title>
	<detailed_description />
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>BMI : &gt; 18 &lt; 30 kg/mÂ² Healthy female volunteer Age 4575 year Postmenopausal state Contraindications use combine ( Estradiol Valerate/dienogest ) contraceptive ( e.g.history venous/arterial thromboembolic disease ) Regular intake medication Clinically relevant finding ( ECG , blood pressure , physical gynaecological examination , laboratory examination ) Smoking</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Female Contraception</keyword>
	<keyword>Contraceptives , Oral</keyword>
</DOC>